Bio-Techne Corporation
TECH
$62.29
-$1.54-2.41%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -1.00% | 3.55% | 4.20% | 8.96% | 4.52% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.00% | 3.55% | 4.20% | 8.96% | 4.52% |
| Cost of Revenue | -4.92% | 4.72% | 3.15% | 5.93% | 10.69% |
| Gross Profit | 1.11% | 2.97% | 4.71% | 10.58% | 1.47% |
| SG&A Expenses | 9.30% | -38.87% | 38.75% | 12.32% | 5.95% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.49% | -11.53% | 17.37% | 9.29% | 7.20% |
| Operating Income | -17.57% | 47.75% | -38.10% | 7.48% | -6.54% |
| Income Before Tax | 19.47% | -154.87% | -37.34% | 28.42% | -18.94% |
| Income Tax Expenses | 49.23% | -582.85% | 30.44% | 34.85% | 557.91% |
| Earnings from Continuing Operations | 13.65% | -143.55% | -53.96% | 27.03% | -34.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 13.65% | -143.55% | -53.96% | 27.03% | -34.11% |
| EBIT | -17.57% | 47.75% | -38.10% | 7.48% | -6.54% |
| EBITDA | -16.11% | 34.21% | -27.36% | 3.84% | -4.77% |
| EPS Basic | 15.90% | -144.47% | -53.98% | 26.33% | -34.27% |
| Normalized Basic EPS | -15.58% | 61.01% | -33.17% | 7.82% | 6.57% |
| EPS Diluted | 14.29% | -145.25% | -54.84% | 29.41% | -32.26% |
| Normalized Diluted EPS | -14.71% | 62.97% | -32.52% | 8.06% | 7.38% |
| Average Basic Shares Outstanding | -1.93% | -1.87% | 0.04% | 0.57% | 0.25% |
| Average Diluted Shares Outstanding | -2.95% | -3.05% | -0.97% | 0.35% | -0.51% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.14% | -3.25% | 1.17% | -0.20% | 0.52% |